Drug developed with $35M in federal funds; Merck expected to reap billions.
Seqera Labs grabs $5.5M to help sequence Covid-19 variants and other complex data problems
Bringing order and understanding to unstructured information located across disparate silos has been one of more significant breakthroughs of the big data era, and today a European startup that has built a platform to help with this challenge specifically in the area of life sciences — and has, notably, been used by labs to sequence […]
costs $56,000 per year
A few weeks ago, the FDA approved a costly Alzheimer’s drug developed by Biogen, but for what benefit?1. There is not strong evidence that Amyloid beta plaques causes Alzheimer’s disease, even if aducanumab showed a reduction in those plaques.2. Aducan…